Ahead of HealthEquity (HQY) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2026.
Wall Street analysts forecast that HealthEquity (HQY) will report quarterly earnings of $1.19 per share in its upcoming release, pointing to a year-over-year increase of 10.2%. It is anticipated that revenues will amount to $350.23 million, exhibiting an increase of 7.5% compared to the year-ago quarter.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain HealthEquity metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus among analysts is that 'Revenue- Service' will reach $121.10 million. The estimate indicates a change of +2.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Revenue- Custodial' should come in at $177.70 million. The estimate indicates a change of +11.2% from the prior-year quarter.
Analysts predict that the 'Revenue- Interchange' will reach $50.98 million. The estimate indicates a year-over-year change of +6%.
It is projected by analysts that the 'Total HSA Assets' will reach $37.64 billion. Compared to the present estimate, the company reported $33.14 billion in the same quarter last year.
Analysts expect 'HSA Assets - HSA investments' to come in at $20.01 billion. Compared to the present estimate, the company reported $16.10 billion in the same quarter last year.
Analysts forecast 'Total Accounts - CDBs' to reach 7.05 million. Compared to the current estimate, the company reported 7.15 million in the same quarter of the previous year.
The average prediction of analysts places 'Total Accounts' at 17.64 million. The estimate compares to the year-ago value of 17.14 million.
Analysts' assessment points toward 'HSA Assets - HSA cash' reaching $17.63 billion. Compared to the current estimate, the company reported $17.04 billion in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Total Accounts - HSAs' will likely reach 10.59 million. The estimate is in contrast to the year-ago figure of 9.99 million.
View all Key Company Metrics for HealthEquity here>>>HealthEquity shares have witnessed a change of +11.4% in the past month, in contrast to the Zacks S&P 500 composite's +2.3% move. With a Zacks Rank #3 (Hold), HQY is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HealthEquity, Inc. (HQY): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).